Key Takeaways:
US companies are selling more stock than ever before, yet share buybacks are absorbing enough of the supply to keep net equity flows positive for the first time in a decade.
US equity issuance is poised to reach record highs in 2026, with UBS estimating initial public offerings could total $200 billion to $350 billion and secondary offerings an additional $400 billion — both all-time highs. The combined $600 billion to $750 billion pipeline would surpass the previous record of $520 billion set in 2021, when SPAC issuance inflated the tally.
"Record issuance is not a threat to equity markets as long as buybacks remain robust," said Lori Calvasina, head of US equity strategy at RBC Capital Markets. "The net supply picture is actually the most favorable we have seen in years."
The buyback counterweight is substantial. S&P 500 companies are on track to repurchase roughly $1 trillion of their own shares in 2026, according to data compiled by Goldman Sachs, more than offsetting the gross issuance pipeline. That would mark the first calendar year since 2014 in which net equity capital returned to shareholders exceeded new supply from issuers, a dynamic that strategists say supports valuations even as the primary market runs hot.
The surge in issuance reflects a confluence of factors. Private equity firms are rushing to exit long-held portfolio companies through IPOs, with names including SpaceX, OpenAI and several large healthcare platforms expected to list this year. Secondary offerings are being driven by companies seeking to fund AI-related capital expenditure and bolt-on acquisitions. The last time issuance approached these levels was in the first half of 2021, when the S&P 500 rose 15 percent over the subsequent six months as buyback activity also accelerated.
Where the supply is concentrated
The composition of this year's issuance matters for sector allocation. Technology and healthcare account for roughly 55 percent of the IPO pipeline, while financials and industrials dominate secondary offerings, according to UBS. That concentration means the supply overhang is not evenly distributed — sectors with heavy buyback programs, particularly technology, are better positioned to absorb the dilution than capital-intensive industries where companies tend to retain cash.
For investors, the key question is whether buyback activity can sustain its current pace. Corporate share repurchases are highly sensitive to earnings growth and management confidence. If the Federal Reserve's hawkish tilt — half of FOMC members now project a rate hike by year-end — begins to weigh on economic activity, companies could pull back on buybacks just as the issuance pipeline reaches its peak. The next two quarters will test whether the net positive equity flow thesis holds.
This article is for informational purposes only and does not constitute investment advice.
